fbpx

Better Access to Liver Cancer Medicines

Posted 05 October, 2020
Other News
The Mediterranean Pathway to Better Mental and Liver Health
< 1 min read
Posted 12 October, 2021

One of the most important things you can do to improve your mental wellbeing is…

Read Article
The Ultimate Guide To Liver Supplements
< 1 min read
Posted 11 August, 2021

With liver disease on the rise across Australia, it's not surprising that we're seeing more…

Read Article
New Liver Disease Nursing Scholarships
< 1 min read
Posted 14 July, 2021

Practice nurses are invited to apply for a new scholarship funding the cost of liver…

Read Article

Australians living with liver cancer will soon have new treatment options with changes to the Pharmaceutical Benefits Scheme (PBS) coming into effect.

The changes include better access to treatments for patients with advanced unresectable hepatocellular carcinoma. Unresectable hepatocellular carcinoma is the most common form of liver cancer, which often occurs in people with other chronic liver diseases. It also has one of the lowest survival rates of all cancer types.

From 1 November, more than 500 patients per year could benefit from PBS listing of this treatment, which would otherwise cost more than $170,000 per course. Australia will be the first country in the world to have this combination treatment publically funded for this type of liver cancer.


Latest News
View Resource
View Resource
View Resource

This website may contain the names and images of Aboriginal and Torres Strait Islander people who have passed on.

CLOSE